Iceland gets new medical devices competent authority - update
This article was originally published in RAJ Devices
The Icelandic Medicines Agency has, as of 1 May, taken up the role of regulating medical devices in the country1. Previously, the Directorate of Health had been responsible for medtech policy-making, inspections and market surveillance2.
You may also be interested in...
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.